ReviewThoracic cancer2022

Predicting the efficacy of first-line immunotherapy by combining cancer cachexia and tumor burden in advanced non-small cell lung cancer.

Taichi Miyawaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.